 |
| About Us |
Sanofi-aventis U.S., based in Bridgewater, NJ, and employing 15,000 people across the country, is part of a leading global pharmaceutical company that discovers, develops, produces and markets innovative therapies that enhance people’s lives. Our extensive research and development efforts are focused on health care challenges in cardiology, oncology and internal medicine, as well as metabolic diseases, central nervous system disorders and vaccines. Read more
|
|
|
|
|
| Quick Links |
|
|
|
| Latest News |
|
| June 17, 2010 |
| Jevtana® (cabazitaxel) Injection Approved by U.S. FDA After Priority Review |
|
|
|
|
| May 05, 2010 |
| Sanofi-aventis Joins the Massachusetts Life Sciences Center’s Corporate Consortium Program to Support Innovation in Research & Development |
|
|
|
|
| April 29, 2010 |
| Q1 2010: A good first quarter |
|
|
|
|
| March 12, 2010 |
| Sanofi-aventis and Bristol-Myers Squibb Announce Important Updates to PLAVIX® U.S. Prescribing Information |
|
|
|
|
